Concerns over Trump's 'man on the Hill' links to Aussie biotech ignored


It was as early as February 2017 when concerns about the conduct of US President Donald Trump's "man on the hill", Chris Collins, were first raised with regulators, including that he had allegedly contravened Australian corporations law. But local regulators chose not to act.



from Biotech News